Fasting plasma glucose variability as a risk factor of retinopathy in Type 2 diabetic patients (Q44340906)

2 December 2017

Fasting plasma glucose variability as a risk factor of retinopathy in Type 2 diabetic patients (English)

1 reference

2 December 2017

0 references

0 references

0 references

José A Gimeno-Orna

1

1 reference

2 December 2017

Francisco J Castro-Alonso

series ordinal

2

1 reference

2 December 2017

Beatriz Boned-Juliani

series ordinal

3

1 reference

2 December 2017

Luis M Lou-Arnal

series ordinal

4

1 reference

2 December 2017

1 March 2003

1 reference

Journal of Diabetes and its Complications

2 December 2017

1 reference

2 December 2017

17

1 reference

2 December 2017

78-81

1 reference

2 December 2017

2

1 reference

Nonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetes.

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900197-6

7 January 2021

The emerging role of post-prandial hyperglycaemic spikes in the pathogenesis of diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900197-6

7 January 2021

Intermittent high glucose enhances cell growth and collagen synthesis in cultured human tubulointerstitial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900197-6

7 January 2021

Hyperglycemia and microvascular and macrovascular disease in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900197-6

7 January 2021

Cultured retinal capillary pericytes die by apoptosis after an abrupt fluctuation from high to low glucose levels: a comparative study with retinal capillary endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900197-6

7 January 2021

Fasting plasma glucose variability predicts 10-year survival of type 2 diabetic patients: the Verona Diabetes Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900197-6

7 January 2021

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900197-6

7 January 2021

The influence of plasma glucose upon pulsatile ocular blood flow in subjects with type II diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900197-6

7 January 2021

The relation of glycaemia to the risk of development and progression of retinopathy in the Diabetic Control and Complications Trial

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900197-6

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900197-6

7 January 2021

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900197-6

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900197-6

7 January 2021

Occurrence and predictors of retinopathy and visual acuity in Type 2 diabetic patients and control subjects. 10-year follow-up from the diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900197-6

7 January 2021

Risk of developing retinopathy in Diabetes Control and Complications Trial type 1 diabetic patients with good or poor metabolic control

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900197-6

7 January 2021

10.1016/S1056-8727(02)00197-6

Identifiers

DOI

1 reference

2 December 2017

1 reference